Sameek Singh Email & Phone Number

Cambridge, MA, US

Cambridge, Massachusetts, United States

Developed a new class of chimeric molecules using DNA-encoded library screening. These bifunctional molecules induce synthetic proximity between specific components of the immune system and pathogens.Leveraged chemoproteomic, computational chemistry approaches to create a new generation of protein editors, including phosphorylation-inducing chimeric.

Hamilton, New Zealand

Involved in the development of cannabinoid therapies for neurological and immunological disorders. This involved identifying novel cannabinoids, designing drug delivery systems, and conducting preclinical studies. Collaborated extensively with academic and industry partners to advance these therapies.

Dunedin

Developed chemical tools to study class A GPCRs (A1AR, CB1R, and CB2R) which regulate many neurological and immune functions. These projects led to the first high-affinity fluorescent inverse agonist for CB2R which was used in live-cell imaging studies of these receptors. Techniques such as organic synthesis, homology modeling, docking, radioligand binding.

Noida

Contributed to the developement of a preclinical candidate targeting IDO1 (indoleamine-2, 3-dioxygenase-1) and TDO (tryptophan-2, 3-dioxygenase))

Kanpur Area, India

Developement of inhibitors targeting IDO1 (indoleamine-2, 3-dioxygenase-1) and TDO (tryptophan-2, 3-dioxygenase))

Chandigarh Area, India

Developed imidazolidinone chiral auxiliary mediated stereoselective route for the synthesis of oxyneolignane natural products which showed potent inhibition of nitric oxide synthase activity in mouse peritoneal macrophages.

Shimla Area, India

Development of pharmaceutical formulations and analysis of Isoniazid in commercial products

Doctor Of Philosophy - Phd, Medicinal Chemistry

M.S., Medicinal Chemistry

B. Pharma